

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | germinal center formation (GO:0002467) | 4.36758265 |
| 2 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.09079682 |
| 3 | growth hormone receptor signaling pathway (GO:0060396) | 3.62294571 |
| 4 | type I interferon signaling pathway (GO:0060337) | 3.49208249 |
| 5 | cellular response to type I interferon (GO:0071357) | 3.49208249 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.48641726 |
| 7 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.48187064 |
| 8 | response to type I interferon (GO:0034340) | 3.46869770 |
| 9 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.40990590 |
| 10 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.35291580 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.32196749 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.32196749 |
| 13 | valine metabolic process (GO:0006573) | 3.31941152 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.31538796 |
| 15 | regulation of cholesterol homeostasis (GO:2000188) | 3.28785194 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.24658558 |
| 17 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.21919314 |
| 18 | B cell receptor signaling pathway (GO:0050853) | 3.19494518 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.17664101 |
| 20 | positive regulation of histone deacetylation (GO:0031065) | 3.13325084 |
| 21 | cellular response to growth hormone stimulus (GO:0071378) | 3.10507721 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 3.09869440 |
| 23 | positive thymic T cell selection (GO:0045059) | 3.05109924 |
| 24 | myeloid dendritic cell differentiation (GO:0043011) | 3.02832686 |
| 25 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.00820855 |
| 26 | positive regulation of p38MAPK cascade (GO:1900745) | 3.00229478 |
| 27 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.97912579 |
| 28 | T-helper cell differentiation (GO:0042093) | 2.97912579 |
| 29 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.96237962 |
| 30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.91917335 |
| 31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.90870356 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 2.90259340 |
| 33 | regulation of interferon-alpha production (GO:0032647) | 2.89986884 |
| 34 | defense response to protozoan (GO:0042832) | 2.87113021 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.87086803 |
| 36 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.86189884 |
| 37 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.85208905 |
| 38 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.85208905 |
| 39 | response to peptidoglycan (GO:0032494) | 2.84510759 |
| 40 | histone H3-K36 demethylation (GO:0070544) | 2.84309248 |
| 41 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.83265222 |
| 42 | positive regulation of fatty acid oxidation (GO:0046321) | 2.80975935 |
| 43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80567314 |
| 44 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.80260684 |
| 45 | regulation of p38MAPK cascade (GO:1900744) | 2.79539032 |
| 46 | positive regulation of type 2 immune response (GO:0002830) | 2.75820811 |
| 47 | 2-oxoglutarate metabolic process (GO:0006103) | 2.69561446 |
| 48 | negative regulation of fatty acid transport (GO:2000192) | 2.69436441 |
| 49 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.69121737 |
| 50 | low-density lipoprotein particle clearance (GO:0034383) | 2.68551637 |
| 51 | response to protozoan (GO:0001562) | 2.67244821 |
| 52 | positive regulation of interferon-alpha production (GO:0032727) | 2.66925200 |
| 53 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.65649302 |
| 54 | positive regulation of extracellular matrix organization (GO:1903055) | 2.65199568 |
| 55 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.65057204 |
| 56 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.63691706 |
| 57 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.61326915 |
| 58 | positive regulation of lipid storage (GO:0010884) | 2.61224277 |
| 59 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.61118948 |
| 60 | cellular response to interleukin-15 (GO:0071350) | 2.61029780 |
| 61 | B cell proliferation (GO:0042100) | 2.60419435 |
| 62 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.60076203 |
| 63 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.60076203 |
| 64 | modulation by symbiont of host immune response (GO:0052553) | 2.60076203 |
| 65 | positive regulation by symbiont of host defense response (GO:0052509) | 2.60076203 |
| 66 | modulation by symbiont of host defense response (GO:0052031) | 2.60076203 |
| 67 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.60076203 |
| 68 | myeloid dendritic cell activation (GO:0001773) | 2.59610086 |
| 69 | positive regulation of B cell proliferation (GO:0030890) | 2.59432551 |
| 70 | alpha-linolenic acid metabolic process (GO:0036109) | 2.59118089 |
| 71 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.57699909 |
| 72 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.56922185 |
| 73 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.56246918 |
| 74 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.56081130 |
| 75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.54677052 |
| 76 | sarcomere organization (GO:0045214) | 2.54549918 |
| 77 | thymic T cell selection (GO:0045061) | 2.53490140 |
| 78 | regulation of fatty acid oxidation (GO:0046320) | 2.52212190 |
| 79 | carnitine shuttle (GO:0006853) | 2.52088616 |
| 80 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.51430416 |
| 81 | fatty acid transmembrane transport (GO:1902001) | 2.50750127 |
| 82 | B cell homeostasis (GO:0001782) | 2.50348448 |
| 83 | immunoglobulin mediated immune response (GO:0016064) | 2.49851735 |
| 84 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.49682887 |
| 85 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.48756959 |
| 86 | negative thymic T cell selection (GO:0045060) | 2.48036743 |
| 87 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.47763288 |
| 88 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.47763288 |
| 89 | T cell differentiation involved in immune response (GO:0002292) | 2.47763288 |
| 90 | response to laminar fluid shear stress (GO:0034616) | 2.47131288 |
| 91 | positive regulation of lipid catabolic process (GO:0050996) | 2.46103509 |
| 92 | tolerance induction (GO:0002507) | 2.45713753 |
| 93 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.45342520 |
| 94 | regulation of type 2 immune response (GO:0002828) | 2.45160619 |
| 95 | creatine metabolic process (GO:0006600) | 2.44294779 |
| 96 | detection of other organism (GO:0098543) | 2.42296532 |
| 97 | phospholipid homeostasis (GO:0055091) | 2.42034440 |
| 98 | regulation of cholesterol storage (GO:0010885) | 2.41820788 |
| 99 | positive T cell selection (GO:0043368) | 2.41516929 |
| 100 | modulation by symbiont of host cellular process (GO:0044068) | 2.40694950 |
| 101 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.39930612 |
| 102 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.39920047 |
| 103 | positive regulation of humoral immune response (GO:0002922) | 2.39808654 |
| 104 | negative regulation of T cell mediated immunity (GO:0002710) | 2.39566235 |
| 105 | tricarboxylic acid metabolic process (GO:0072350) | 2.39292048 |
| 106 | detection of molecule of bacterial origin (GO:0032490) | 2.38565968 |
| 107 | regulation of T-helper cell differentiation (GO:0045622) | 2.37837539 |
| 108 | positive regulation of glycogen metabolic process (GO:0070875) | 2.37625522 |
| 109 | negative T cell selection (GO:0043383) | 2.37573080 |
| 110 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.37525986 |
| 111 | negative regulation of lipid transport (GO:0032369) | 2.37361441 |
| 112 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.35918923 |
| 113 | neutrophil activation involved in immune response (GO:0002283) | 2.35390610 |
| 114 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.34033294 |
| 115 | lysine metabolic process (GO:0006553) | 2.33012395 |
| 116 | lysine catabolic process (GO:0006554) | 2.33012395 |
| 117 | regulation of extracellular matrix organization (GO:1903053) | 2.32800268 |
| 118 | T-helper 1 type immune response (GO:0042088) | 2.32740984 |
| 119 | regulation of necroptotic process (GO:0060544) | 2.32598157 |
| 120 | cellular response to virus (GO:0098586) | 2.32509131 |
| 121 | detection of bacterium (GO:0016045) | 2.32307475 |
| 122 | NIK/NF-kappaB signaling (GO:0038061) | 2.31269264 |
| 123 | granulocyte activation (GO:0036230) | 2.31002885 |
| 124 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.30657239 |
| 125 | T cell selection (GO:0045058) | 2.30330673 |
| 126 | skeletal muscle adaptation (GO:0043501) | 2.29012758 |
| 127 | regulation of sequestering of triglyceride (GO:0010889) | 2.28156959 |
| 128 | positive regulation of heat generation (GO:0031652) | 2.25316218 |
| 129 | negative regulation of lipid storage (GO:0010888) | 2.25295936 |
| 130 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.24450804 |
| 131 | striated muscle atrophy (GO:0014891) | 2.24247089 |
| 132 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.22485374 |
| 133 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.20036053 |
| 134 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.19138136 |
| 135 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.18553411 |
| 136 | oxaloacetate metabolic process (GO:0006107) | 2.18355800 |
| 137 | myofibril assembly (GO:0030239) | 2.18185375 |
| 138 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.16073240 |
| 139 | leukocyte aggregation (GO:0070486) | 2.14700178 |
| 140 | cellular response to zinc ion (GO:0071294) | 2.14550181 |
| 141 | cardiac myofibril assembly (GO:0055003) | 2.13227295 |
| 142 | regulation of T cell tolerance induction (GO:0002664) | 2.12151515 |
| 143 | cellular response to nicotine (GO:0071316) | 2.09400915 |
| 144 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.07857900 |
| 145 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.06121607 |
| 146 | apoptotic cell clearance (GO:0043277) | 2.05472630 |
| 147 | response to interleukin-15 (GO:0070672) | 2.04817933 |
| 148 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.03468281 |
| 149 | regulation of lipid storage (GO:0010883) | 2.03442568 |
| 150 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.01986191 |
| 151 | regulation of lipid catabolic process (GO:0050994) | 2.00393575 |
| 152 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 1.99806902 |
| 153 | regulation of skeletal muscle contraction (GO:0014819) | 1.99270282 |
| 154 | plasma membrane repair (GO:0001778) | 1.97937471 |
| 155 | negative regulation of cell killing (GO:0031342) | 1.97403820 |
| 156 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 1.97403820 |
| 157 | muscle filament sliding (GO:0030049) | 1.96734601 |
| 158 | actin-myosin filament sliding (GO:0033275) | 1.96734601 |
| 159 | positive regulation of fatty acid metabolic process (GO:0045923) | 1.96649705 |
| 160 | negative regulation of cholesterol transport (GO:0032375) | 1.96430222 |
| 161 | negative regulation of sterol transport (GO:0032372) | 1.96430222 |
| 162 | activation of MAPKKK activity (GO:0000185) | 1.96147100 |
| 163 | positive regulation of steroid biosynthetic process (GO:0010893) | 1.95671914 |
| 164 | protein carboxylation (GO:0018214) | 1.95574946 |
| 165 | peptidyl-glutamic acid carboxylation (GO:0017187) | 1.95574946 |
| 166 | regulation of triglyceride biosynthetic process (GO:0010866) | 1.95570433 |
| 167 | response to muramyl dipeptide (GO:0032495) | 1.94748519 |
| 168 | fatty acid beta-oxidation (GO:0006635) | 1.94415128 |
| 169 | dicarboxylic acid biosynthetic process (GO:0043650) | 1.93730861 |
| 170 | positive regulation of interleukin-2 production (GO:0032743) | 1.93582447 |
| 171 | regulation of NFAT protein import into nucleus (GO:0051532) | 1.93352396 |
| 172 | macroautophagy (GO:0016236) | 1.92834460 |
| 173 | carnitine transmembrane transport (GO:1902603) | 1.92369742 |
| 174 | positive regulation of glycolytic process (GO:0045821) | 1.91830441 |
| 175 | positive regulation of tolerance induction (GO:0002645) | 1.90156675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.53480237 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.27066965 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.11872059 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.09363004 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.67983852 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.61036392 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.59504211 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.54103731 |
| 9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.47534445 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.44018335 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.40563842 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.18482529 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.12661244 |
| 14 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.07915344 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.02364273 |
| 16 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.99272948 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.90775342 |
| 18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.90538686 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.88929747 |
| 20 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.82259706 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78278368 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71461030 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.70955415 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65121121 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.64630186 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.56580988 |
| 27 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.56395981 |
| 28 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.55599810 |
| 29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.54852827 |
| 30 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54816559 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54784595 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.54235043 |
| 33 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.53518839 |
| 34 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52845891 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52786603 |
| 36 | * MYC_22102868_ChIP-Seq_BL_Human | 1.51716366 |
| 37 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.49999891 |
| 38 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.49999891 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46541040 |
| 40 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46337142 |
| 41 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45411295 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.44337074 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43370036 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41429842 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40577226 |
| 46 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.40214505 |
| 47 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.35924383 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34595981 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33231267 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.32216590 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.31385965 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28467026 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26386782 |
| 54 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26094354 |
| 55 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25863738 |
| 56 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25512175 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25461004 |
| 58 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.25200931 |
| 59 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25180648 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22258161 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21910393 |
| 62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21745144 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20759001 |
| 64 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18046134 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17985147 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16186491 |
| 67 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.15230931 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15190561 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13748909 |
| 70 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13664030 |
| 71 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.12373941 |
| 72 | * MAF_26560356_Chip-Seq_TH2_Human | 1.12068771 |
| 73 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11389946 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09055476 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08439123 |
| 76 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06278151 |
| 77 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.05312169 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05044557 |
| 79 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04937639 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04628413 |
| 81 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04116979 |
| 82 | MYB_26560356_Chip-Seq_TH2_Human | 1.03683257 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02875641 |
| 84 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02554100 |
| 85 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.02475442 |
| 86 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.02428429 |
| 87 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01284364 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01159236 |
| 89 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.00848436 |
| 90 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00529988 |
| 91 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00419681 |
| 92 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00261786 |
| 93 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.99845517 |
| 94 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.99458852 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99381026 |
| 96 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98352320 |
| 97 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.97684166 |
| 98 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97374957 |
| 99 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97330205 |
| 100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97252303 |
| 101 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.96783022 |
| 102 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96007964 |
| 103 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.95901481 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95356593 |
| 105 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.93999149 |
| 106 | CJUN_26792858_Chip-Seq_BT549_Human | 0.93610023 |
| 107 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93520317 |
| 108 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.93443496 |
| 109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92867304 |
| 110 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92422434 |
| 111 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92146934 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91909380 |
| 113 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90026866 |
| 114 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.89901974 |
| 115 | MYB_26560356_Chip-Seq_TH1_Human | 0.89857097 |
| 116 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.88251710 |
| 117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87949732 |
| 118 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86682190 |
| 119 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84843208 |
| 120 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84269112 |
| 121 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80219263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004510_myositis | 3.19495877 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.09439957 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 2.80663934 |
| 4 | MP0003303_peritoneal_inflammation | 2.79424662 |
| 5 | MP0005451_abnormal_body_composition | 2.44197753 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.43762939 |
| 7 | MP0002254_reproductive_system_inflammat | 2.37792809 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.30308302 |
| 9 | MP0005360_urolithiasis | 2.18176487 |
| 10 | MP0000685_abnormal_immune_system | 2.16507388 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.12522131 |
| 12 | MP0001790_abnormal_immune_system | 2.10891318 |
| 13 | MP0005387_immune_system_phenotype | 2.10891318 |
| 14 | MP0004130_abnormal_muscle_cell | 2.02068450 |
| 15 | MP0005365_abnormal_bile_salt | 1.99693546 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 1.98394380 |
| 17 | MP0003436_decreased_susceptibility_to | 1.98027865 |
| 18 | MP0003252_abnormal_bile_duct | 1.90778784 |
| 19 | MP0006082_CNS_inflammation | 1.85681391 |
| 20 | MP0008961_abnormal_basal_metabolism | 1.84194688 |
| 21 | MP0003646_muscle_fatigue | 1.76470235 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 1.75572823 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.73257179 |
| 24 | MP0005058_abnormal_lysosome_morphology | 1.73007805 |
| 25 | MP0003183_abnormal_peptide_metabolism | 1.67599580 |
| 26 | MP0000751_myopathy | 1.67589062 |
| 27 | MP0003724_increased_susceptibility_to | 1.63454067 |
| 28 | MP0003690_abnormal_glial_cell | 1.63124749 |
| 29 | MP0004084_abnormal_cardiac_muscle | 1.61474127 |
| 30 | MP0002398_abnormal_bone_marrow | 1.57575800 |
| 31 | MP0005670_abnormal_white_adipose | 1.57385021 |
| 32 | MP0000716_abnormal_immune_system | 1.55568675 |
| 33 | MP0004087_abnormal_muscle_fiber | 1.55269246 |
| 34 | MP0001800_abnormal_humoral_immune | 1.52141205 |
| 35 | MP0004036_abnormal_muscle_relaxation | 1.51055171 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.49872950 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.49273523 |
| 38 | MP0004947_skin_inflammation | 1.47104201 |
| 39 | MP0010329_abnormal_lipoprotein_level | 1.46439226 |
| 40 | MP0001835_abnormal_antigen_presentation | 1.46000210 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.45450284 |
| 42 | MP0000749_muscle_degeneration | 1.42727037 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.42596097 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.40318848 |
| 45 | MP0005076_abnormal_cell_differentiation | 1.37830277 |
| 46 | MP0010368_abnormal_lymphatic_system | 1.35337913 |
| 47 | MP0005375_adipose_tissue_phenotype | 1.34224970 |
| 48 | MP0000733_abnormal_muscle_development | 1.33560791 |
| 49 | MP0009840_abnormal_foam_cell | 1.31431509 |
| 50 | MP0010630_abnormal_cardiac_muscle | 1.31309347 |
| 51 | MP0005310_abnormal_salivary_gland | 1.30548949 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.30530930 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.30421930 |
| 54 | MP0001853_heart_inflammation | 1.29066192 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.28769888 |
| 56 | MP0000609_abnormal_liver_physiology | 1.28506241 |
| 57 | MP0003045_fibrosis | 1.26537384 |
| 58 | MP0009785_altered_susceptibility_to | 1.25380947 |
| 59 | MP0005085_abnormal_gallbladder_physiolo | 1.25164423 |
| 60 | MP0004381_abnormal_hair_follicle | 1.22349856 |
| 61 | MP0000858_altered_metastatic_potential | 1.21078855 |
| 62 | MP0005330_cardiomyopathy | 1.20946166 |
| 63 | MP0002722_abnormal_immune_system | 1.20906866 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.20324472 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.20147011 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.19806500 |
| 67 | MP0008875_abnormal_xenobiotic_pharmacok | 1.18733029 |
| 68 | MP0000750_abnormal_muscle_regeneration | 1.18697703 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.18568400 |
| 70 | MP0004185_abnormal_adipocyte_glucose | 1.17740022 |
| 71 | MP0003828_pulmonary_edema | 1.17733251 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.15644017 |
| 73 | MP0002452_abnormal_antigen_presenting | 1.13530537 |
| 74 | MP0002972_abnormal_cardiac_muscle | 1.12746609 |
| 75 | MP0002723_abnormal_immune_serum | 1.12689309 |
| 76 | MP0000003_abnormal_adipose_tissue | 1.11545921 |
| 77 | MP0002429_abnormal_blood_cell | 1.11526619 |
| 78 | MP0003091_abnormal_cell_migration | 1.10842086 |
| 79 | MP0002933_joint_inflammation | 1.09851579 |
| 80 | MP0005671_abnormal_response_to | 1.08863171 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 1.08167391 |
| 82 | MP0002971_abnormal_brown_adipose | 1.07108712 |
| 83 | MP0009764_decreased_sensitivity_to | 1.07066013 |
| 84 | MP0002106_abnormal_muscle_physiology | 1.06183523 |
| 85 | MP0010155_abnormal_intestine_physiology | 1.05627270 |
| 86 | MP0009278_abnormal_bone_marrow | 1.05019616 |
| 87 | MP0006054_spinal_hemorrhage | 1.03935105 |
| 88 | MP0002006_tumorigenesis | 1.03608149 |
| 89 | MP0002118_abnormal_lipid_homeostasis | 1.03427982 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 1.03002929 |
| 91 | MP0002405_respiratory_system_inflammati | 1.02917989 |
| 92 | MP0002419_abnormal_innate_immunity | 1.02294209 |
| 93 | MP0002998_abnormal_bone_remodeling | 1.02094190 |
| 94 | MP0005166_decreased_susceptibility_to | 1.01724652 |
| 95 | MP0005025_abnormal_response_to | 1.00539963 |
| 96 | MP0003866_abnormal_defecation | 0.99630148 |
| 97 | MP0000759_abnormal_skeletal_muscle | 0.99075734 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.99016465 |
| 99 | MP0001851_eye_inflammation | 0.98774702 |
| 100 | MP0004883_abnormal_blood_vessel | 0.98672598 |
| 101 | MP0009780_abnormal_chondrocyte_physiolo | 0.98044556 |
| 102 | MP0005620_abnormal_muscle_contractility | 0.97898691 |
| 103 | MP0003279_aneurysm | 0.97118913 |
| 104 | MP0001879_abnormal_lymphatic_vessel | 0.96933821 |
| 105 | MP0002168_other_aberrant_phenotype | 0.96800507 |
| 106 | MP0000604_amyloidosis | 0.95693941 |
| 107 | MP0008004_abnormal_stomach_pH | 0.95511324 |
| 108 | MP0004215_abnormal_myocardial_fiber | 0.93993553 |
| 109 | MP0005385_cardiovascular_system_phenoty | 0.93893525 |
| 110 | MP0001544_abnormal_cardiovascular_syste | 0.93893525 |
| 111 | MP0000249_abnormal_blood_vessel | 0.93893307 |
| 112 | MP0002420_abnormal_adaptive_immunity | 0.92182402 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.91925687 |
| 114 | MP0000465_gastrointestinal_hemorrhage | 0.91612608 |
| 115 | MP0005464_abnormal_platelet_physiology | 0.91591401 |
| 116 | MP0003195_calcinosis | 0.91267384 |
| 117 | MP0008260_abnormal_autophagy | 0.90712723 |
| 118 | MP0001819_abnormal_immune_cell | 0.90663583 |
| 119 | MP0003448_altered_tumor_morphology | 0.90563274 |
| 120 | MP0002234_abnormal_pharynx_morphology | 0.89411463 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.88787020 |
| 122 | MP0000767_abnormal_smooth_muscle | 0.87436284 |
| 123 | MP0000920_abnormal_myelination | 0.87175706 |
| 124 | MP0002269_muscular_atrophy | 0.86690149 |
| 125 | MP0008775_abnormal_heart_ventricle | 0.86052355 |
| 126 | MP0005369_muscle_phenotype | 0.84594601 |
| 127 | MP0000747_muscle_weakness | 0.83563366 |
| 128 | MP0005334_abnormal_fat_pad | 0.83504535 |
| 129 | MP0008469_abnormal_protein_level | 0.83205735 |
| 130 | MP0001873_stomach_inflammation | 0.83095735 |
| 131 | MP0005023_abnormal_wound_healing | 0.82850194 |
| 132 | MP0005164_abnormal_response_to | 0.82485353 |
| 133 | MP0002078_abnormal_glucose_homeostasis | 0.82183708 |
| 134 | MP0002909_abnormal_adrenal_gland | 0.81887620 |
| 135 | MP0002009_preneoplasia | 0.81473466 |
| 136 | MP0003075_altered_response_to | 0.80694449 |
| 137 | MP0001915_intracranial_hemorrhage | 0.80312786 |
| 138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79290257 |
| 139 | MP0004233_abnormal_muscle_weight | 0.76919018 |
| 140 | MP0005397_hematopoietic_system_phenotyp | 0.76239661 |
| 141 | MP0001545_abnormal_hematopoietic_system | 0.76239661 |
| 142 | MP0004808_abnormal_hematopoietic_stem | 0.74408918 |
| 143 | MP0009115_abnormal_fat_cell | 0.72063928 |
| 144 | MP0003868_abnormal_feces_composition | 0.71906739 |
| 145 | MP0009763_increased_sensitivity_to | 0.69534597 |
| 146 | MP0001663_abnormal_digestive_system | 0.68412471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 3.44858926 |
| 2 | Exercise-induced myalgia (HP:0003738) | 3.42550720 |
| 3 | T lymphocytopenia (HP:0005403) | 3.21852512 |
| 4 | Mediastinal lymphadenopathy (HP:0100721) | 3.21783697 |
| 5 | Hyporeflexia of lower limbs (HP:0002600) | 3.16398800 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 3.16030687 |
| 7 | Myocardial infarction (HP:0001658) | 3.12583455 |
| 8 | Glomerulonephritis (HP:0000099) | 3.11023405 |
| 9 | Keratoconjunctivitis sicca (HP:0001097) | 3.04356325 |
| 10 | Meningitis (HP:0001287) | 3.01590002 |
| 11 | Sudden death (HP:0001699) | 2.96727833 |
| 12 | Abnormality of macrophages (HP:0004311) | 2.96114999 |
| 13 | Muscle fiber splitting (HP:0003555) | 2.92953699 |
| 14 | Eczematoid dermatitis (HP:0000976) | 2.81899554 |
| 15 | Mitral stenosis (HP:0001718) | 2.80696931 |
| 16 | Asymmetric septal hypertrophy (HP:0001670) | 2.79350833 |
| 17 | Increased density of long bones (HP:0006392) | 2.78780915 |
| 18 | Calf muscle hypertrophy (HP:0008981) | 2.73576674 |
| 19 | Exercise-induced muscle cramps (HP:0003710) | 2.72957461 |
| 20 | Subaortic stenosis (HP:0001682) | 2.70531834 |
| 21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.70531834 |
| 22 | Increased connective tissue (HP:0009025) | 2.70053876 |
| 23 | Ventricular tachycardia (HP:0004756) | 2.69866456 |
| 24 | Persistence of primary teeth (HP:0006335) | 2.69082625 |
| 25 | Keratoconjunctivitis (HP:0001096) | 2.64570470 |
| 26 | Agammaglobulinemia (HP:0004432) | 2.64475527 |
| 27 | Myoglobinuria (HP:0002913) | 2.60036958 |
| 28 | Difficulty running (HP:0009046) | 2.58367823 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 2.57868485 |
| 30 | Hypoglycemic coma (HP:0001325) | 2.57577342 |
| 31 | Deep venous thrombosis (HP:0002625) | 2.55354860 |
| 32 | Pulmonary infiltrates (HP:0002113) | 2.52884813 |
| 33 | Ketoacidosis (HP:0001993) | 2.50299354 |
| 34 | Hemorrhage of the eye (HP:0011885) | 2.49720374 |
| 35 | Recurrent abscess formation (HP:0002722) | 2.48475098 |
| 36 | Abnormality of the calf musculature (HP:0001430) | 2.44397173 |
| 37 | Recurrent viral infections (HP:0004429) | 2.42500173 |
| 38 | Increased IgE level (HP:0003212) | 2.41843546 |
| 39 | Recurrent bronchitis (HP:0002837) | 2.40860079 |
| 40 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.39670391 |
| 41 | Cellulitis (HP:0100658) | 2.38631440 |
| 42 | Broad metatarsal (HP:0001783) | 2.37995179 |
| 43 | Autoimmune hemolytic anemia (HP:0001890) | 2.35333973 |
| 44 | Pulmonary embolism (HP:0002204) | 2.32685230 |
| 45 | Type 1 muscle fiber predominance (HP:0003803) | 2.29121908 |
| 46 | Xanthomatosis (HP:0000991) | 2.24354866 |
| 47 | Loss of speech (HP:0002371) | 2.23111107 |
| 48 | Gangrene (HP:0100758) | 2.22527083 |
| 49 | Dysostosis multiplex (HP:0000943) | 2.21759503 |
| 50 | Abnormality of the pleura (HP:0002103) | 2.20606303 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.20533409 |
| 52 | Joint hemorrhage (HP:0005261) | 2.19534238 |
| 53 | Ketosis (HP:0001946) | 2.18977130 |
| 54 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.18134747 |
| 55 | Arterial thrombosis (HP:0004420) | 2.17998167 |
| 56 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.17439445 |
| 57 | EMG: myopathic abnormalities (HP:0003458) | 2.17417710 |
| 58 | Encephalitis (HP:0002383) | 2.17331884 |
| 59 | Hydroxyprolinuria (HP:0003080) | 2.15726461 |
| 60 | Abnormality of proline metabolism (HP:0010907) | 2.15726461 |
| 61 | Abnormality of complement system (HP:0005339) | 2.15657988 |
| 62 | Abnormality of B cell number (HP:0010975) | 2.15551919 |
| 63 | Lipoatrophy (HP:0100578) | 2.14349544 |
| 64 | Esophageal varix (HP:0002040) | 2.13524884 |
| 65 | Gastrointestinal inflammation (HP:0004386) | 2.12911478 |
| 66 | Frequent falls (HP:0002359) | 2.12626785 |
| 67 | Inflammation of the large intestine (HP:0002037) | 2.11165504 |
| 68 | Atrial fibrillation (HP:0005110) | 2.10948831 |
| 69 | Interstitial pulmonary disease (HP:0006530) | 2.09000383 |
| 70 | Bundle branch block (HP:0011710) | 2.08284305 |
| 71 | Joint swelling (HP:0001386) | 2.04916652 |
| 72 | Lymphopenia (HP:0001888) | 2.04855995 |
| 73 | Hyperglycemia (HP:0003074) | 2.03621149 |
| 74 | Aneurysm (HP:0002617) | 2.03538113 |
| 75 | Aortic aneurysm (HP:0004942) | 2.03276578 |
| 76 | Obstructive sleep apnea (HP:0002870) | 2.01974178 |
| 77 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.01917320 |
| 78 | Abnormality of the common coagulation pathway (HP:0010990) | 2.00029259 |
| 79 | Restrictive lung disease (HP:0002091) | 1.99871885 |
| 80 | Stomatitis (HP:0010280) | 1.99823702 |
| 81 | Scapular winging (HP:0003691) | 1.99646081 |
| 82 | Panhypogammaglobulinemia (HP:0003139) | 1.98620553 |
| 83 | Prolonged partial thromboplastin time (HP:0003645) | 1.98318768 |
| 84 | Slow saccadic eye movements (HP:0000514) | 1.97432968 |
| 85 | B lymphocytopenia (HP:0010976) | 1.96590411 |
| 86 | Gastrointestinal stroma tumor (HP:0100723) | 1.96571832 |
| 87 | Orchitis (HP:0100796) | 1.95732527 |
| 88 | Primary atrial arrhythmia (HP:0001692) | 1.95586163 |
| 89 | Neurofibrillary tangles (HP:0002185) | 1.95412262 |
| 90 | Purpura (HP:0000979) | 1.95041732 |
| 91 | Abnormality of the fingertips (HP:0001211) | 1.94888512 |
| 92 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.93816813 |
| 93 | Colitis (HP:0002583) | 1.93167952 |
| 94 | Gingivitis (HP:0000230) | 1.91724047 |
| 95 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91704066 |
| 96 | Mucopolysacchariduria (HP:0008155) | 1.91704066 |
| 97 | Hemoptysis (HP:0002105) | 1.91493476 |
| 98 | Osteomyelitis (HP:0002754) | 1.91296234 |
| 99 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90950958 |
| 100 | Nephritis (HP:0000123) | 1.90117072 |
| 101 | Spontaneous hematomas (HP:0007420) | 1.90028142 |
| 102 | Gastrointestinal infarctions (HP:0005244) | 1.89866542 |
| 103 | Cerebral aneurysm (HP:0004944) | 1.89785513 |
| 104 | Sepsis (HP:0100806) | 1.89101598 |
| 105 | Striae distensae (HP:0001065) | 1.88732173 |
| 106 | Polycythemia (HP:0001901) | 1.87780582 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.86516194 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.86516194 |
| 109 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.86516194 |
| 110 | Amyloidosis (HP:0011034) | 1.86298364 |
| 111 | Macroorchidism (HP:0000053) | 1.85759262 |
| 112 | Chest pain (HP:0100749) | 1.85365280 |
| 113 | Papilloma (HP:0012740) | 1.85290960 |
| 114 | Verrucae (HP:0200043) | 1.85290960 |
| 115 | Hypoplasia of the thymus (HP:0000778) | 1.84785166 |
| 116 | Increased IgM level (HP:0003496) | 1.84264610 |
| 117 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.83701505 |
| 118 | Abnormality of the peritoneum (HP:0002585) | 1.83112636 |
| 119 | Atrioventricular block (HP:0001678) | 1.82897220 |
| 120 | Hypoalphalipoproteinemia (HP:0003233) | 1.82743403 |
| 121 | Recurrent fungal infections (HP:0002841) | 1.82570334 |
| 122 | Polyneuropathy (HP:0001271) | 1.82554867 |
| 123 | Epidermoid cyst (HP:0200040) | 1.81175743 |
| 124 | Subacute progressive viral hepatitis (HP:0006572) | 1.80676512 |
| 125 | Dysmetric saccades (HP:0000641) | 1.79459129 |
| 126 | Peritonitis (HP:0002586) | 1.78684146 |
| 127 | Recurrent skin infections (HP:0001581) | 1.78212047 |
| 128 | Abnormality of the endocardium (HP:0004306) | 1.77679191 |
| 129 | Supraventricular tachycardia (HP:0004755) | 1.76835499 |
| 130 | Severe combined immunodeficiency (HP:0004430) | 1.76590183 |
| 131 | Complement deficiency (HP:0004431) | 1.76405920 |
| 132 | Abnormality of glycolipid metabolism (HP:0010969) | 1.76356606 |
| 133 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.76356606 |
| 134 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.76356606 |
| 135 | Dilated cardiomyopathy (HP:0001644) | 1.75795031 |
| 136 | Supraventricular arrhythmia (HP:0005115) | 1.74916771 |
| 137 | Hypoplastic ischia (HP:0003175) | 1.74906342 |
| 138 | Increased cerebral lipofuscin (HP:0011813) | 1.74556448 |
| 139 | Intrahepatic cholestasis (HP:0001406) | 1.74370009 |
| 140 | Retrobulbar optic neuritis (HP:0100654) | 1.74215970 |
| 141 | Optic neuritis (HP:0100653) | 1.74215970 |
| 142 | Increased variability in muscle fiber diameter (HP:0003557) | 1.74141594 |
| 143 | Distal lower limb amyotrophy (HP:0008944) | 1.72328029 |
| 144 | Syncope (HP:0001279) | 1.72240166 |
| 145 | Difficulty climbing stairs (HP:0003551) | 1.72082077 |
| 146 | Mitral valve prolapse (HP:0001634) | 1.71877011 |
| 147 | Abnormality of T cells (HP:0002843) | 1.70865987 |
| 148 | Eosinophilia (HP:0001880) | 1.70550301 |
| 149 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.70456740 |
| 150 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.70197838 |
| 151 | Viral hepatitis (HP:0006562) | 1.69601288 |
| 152 | Asymmetry of the thorax (HP:0001555) | 1.69300259 |
| 153 | Hypoglycemic seizures (HP:0002173) | 1.68987608 |
| 154 | Periodontitis (HP:0000704) | 1.68887277 |
| 155 | Myositis (HP:0100614) | 1.68435439 |
| 156 | Muscle fiber inclusion bodies (HP:0100299) | 1.67703977 |
| 157 | Abnormality of T cell number (HP:0011839) | 1.66826435 |
| 158 | Prolonged QT interval (HP:0001657) | 1.66647203 |
| 159 | Abnormal atrioventricular conduction (HP:0005150) | 1.66230206 |
| 160 | Ventricular arrhythmia (HP:0004308) | 1.66109234 |
| 161 | Heart block (HP:0012722) | 1.65710516 |
| 162 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.64820600 |
| 163 | Vasculitis (HP:0002633) | 1.64466623 |
| 164 | Gingival bleeding (HP:0000225) | 1.63790405 |
| 165 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.63596648 |
| 166 | Emphysema (HP:0002097) | 1.63582508 |
| 167 | Hematochezia (HP:0002573) | 1.63009164 |
| 168 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.62730536 |
| 169 | Limb-girdle muscle atrophy (HP:0003797) | 1.61127211 |
| 170 | Tetraparesis (HP:0002273) | 1.60943413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.54868151 |
| 2 | SIK1 | 2.68816675 |
| 3 | FGFR4 | 2.60963689 |
| 4 | EPHB1 | 2.53416628 |
| 5 | PRPF4B | 2.48582212 |
| 6 | MAP3K14 | 2.46155572 |
| 7 | ERN1 | 2.44660854 |
| 8 | TTN | 2.43496250 |
| 9 | MAP4K1 | 2.42663752 |
| 10 | RIPK1 | 2.24689193 |
| 11 | EPHA3 | 2.15089595 |
| 12 | MAP3K10 | 2.09341133 |
| 13 | JAK1 | 1.98168803 |
| 14 | RIPK4 | 1.86680354 |
| 15 | IRAK4 | 1.83578237 |
| 16 | TBK1 | 1.82782144 |
| 17 | BLK | 1.82758344 |
| 18 | PKN2 | 1.73952232 |
| 19 | FGFR3 | 1.73067688 |
| 20 | JAK3 | 1.68377783 |
| 21 | DMPK | 1.64230982 |
| 22 | CHUK | 1.63536066 |
| 23 | PTK6 | 1.58019708 |
| 24 | MAP3K7 | 1.55179335 |
| 25 | TYK2 | 1.53928136 |
| 26 | LMTK2 | 1.52468681 |
| 27 | IKBKE | 1.41253432 |
| 28 | ICK | 1.38273870 |
| 29 | PHKG2 | 1.35784507 |
| 30 | PHKG1 | 1.35784507 |
| 31 | TXK | 1.25718333 |
| 32 | IKBKB | 1.25019020 |
| 33 | INSRR | 1.22774608 |
| 34 | SMG1 | 1.21844019 |
| 35 | TAOK2 | 1.18965770 |
| 36 | SGK3 | 1.18052178 |
| 37 | ITK | 1.17249554 |
| 38 | IRAK3 | 1.17225549 |
| 39 | PRKCH | 1.16681720 |
| 40 | TYRO3 | 1.15168372 |
| 41 | FGR | 1.13173257 |
| 42 | KSR2 | 1.13035307 |
| 43 | GRK6 | 1.08689120 |
| 44 | MATK | 1.08382106 |
| 45 | MAP3K3 | 1.06113357 |
| 46 | TNK2 | 1.05562703 |
| 47 | FES | 1.05362414 |
| 48 | MARK2 | 1.04351521 |
| 49 | LRRK2 | 1.02874077 |
| 50 | CSF1R | 1.02565600 |
| 51 | OBSCN | 1.02559537 |
| 52 | TAOK1 | 1.02068703 |
| 53 | CAMK1G | 1.01997183 |
| 54 | MAPK7 | 1.01993677 |
| 55 | FGFR2 | 1.01982045 |
| 56 | CSK | 1.00348837 |
| 57 | CAMK1D | 1.00329189 |
| 58 | HIPK2 | 0.99456444 |
| 59 | TAOK3 | 0.99364378 |
| 60 | DDR2 | 0.98800888 |
| 61 | BMX | 0.98396986 |
| 62 | TGFBR2 | 0.96274494 |
| 63 | JAK2 | 0.95543441 |
| 64 | MAP3K13 | 0.94836869 |
| 65 | CDK4 | 0.94024726 |
| 66 | EEF2K | 0.92544942 |
| 67 | ZAP70 | 0.91722582 |
| 68 | PDGFRA | 0.90895408 |
| 69 | LATS1 | 0.90823973 |
| 70 | MAPK15 | 0.90508444 |
| 71 | HCK | 0.86384257 |
| 72 | IRAK1 | 0.83768035 |
| 73 | LYN | 0.83747481 |
| 74 | CDK12 | 0.83134565 |
| 75 | NLK | 0.82151270 |
| 76 | STK10 | 0.81104006 |
| 77 | BTK | 0.78632131 |
| 78 | IRAK2 | 0.78211790 |
| 79 | RPS6KA4 | 0.76909063 |
| 80 | PDGFRB | 0.75419784 |
| 81 | SGK2 | 0.74055877 |
| 82 | MAP3K11 | 0.73332035 |
| 83 | PRKD1 | 0.71918311 |
| 84 | MAPK4 | 0.71126642 |
| 85 | GSK3A | 0.70474901 |
| 86 | MAP3K2 | 0.70441745 |
| 87 | MTOR | 0.69999660 |
| 88 | MAP3K1 | 0.69316465 |
| 89 | BRD4 | 0.68478042 |
| 90 | MAP2K3 | 0.67684346 |
| 91 | PRKAA2 | 0.66287906 |
| 92 | PIK3CA | 0.64588694 |
| 93 | PDK1 | 0.63375769 |
| 94 | GRK7 | 0.62466292 |
| 95 | FRK | 0.61895350 |
| 96 | PRKCQ | 0.59619088 |
| 97 | MAPKAPK2 | 0.58820949 |
| 98 | MAP2K2 | 0.57776393 |
| 99 | SYK | 0.57006190 |
| 100 | RET | 0.56592543 |
| 101 | PAK3 | 0.56516833 |
| 102 | SIK2 | 0.55229826 |
| 103 | MAPK11 | 0.55165094 |
| 104 | NEK9 | 0.54095091 |
| 105 | PTK2 | 0.53358326 |
| 106 | BMPR2 | 0.53256688 |
| 107 | MARK3 | 0.52838714 |
| 108 | ALK | 0.52541140 |
| 109 | RPS6KC1 | 0.52214159 |
| 110 | RPS6KL1 | 0.52214159 |
| 111 | PIK3CG | 0.51140796 |
| 112 | SIK3 | 0.50789657 |
| 113 | MELK | 0.49630147 |
| 114 | FGFR1 | 0.49409652 |
| 115 | CDK6 | 0.49223000 |
| 116 | PKN1 | 0.48905857 |
| 117 | MST1R | 0.48443037 |
| 118 | SGK223 | 0.48420994 |
| 119 | SGK494 | 0.48420994 |
| 120 | MOS | 0.47019513 |
| 121 | PRKAA1 | 0.46753236 |
| 122 | CAMK4 | 0.46674260 |
| 123 | RPS6KA1 | 0.45964772 |
| 124 | PRKD2 | 0.45308138 |
| 125 | CDC42BPA | 0.45178723 |
| 126 | KSR1 | 0.43999846 |
| 127 | MAPK12 | 0.42368530 |
| 128 | STK24 | 0.42356630 |
| 129 | BCKDK | 0.42250856 |
| 130 | PDPK1 | 0.41453030 |
| 131 | DYRK1B | 0.40917330 |
| 132 | EPHB2 | 0.40687426 |
| 133 | LCK | 0.40138795 |
| 134 | SGK1 | 0.38672233 |
| 135 | WNK1 | 0.38659468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.47673238 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.10633238 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.79573209 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.71802671 |
| 5 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.65882765 |
| 6 | Insulin resistance_Homo sapiens_hsa04931 | 1.64771806 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.58002671 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.54846616 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.47312112 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 1.44206777 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42719280 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.42541865 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37527795 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.37133956 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.33833490 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.33699359 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33516992 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30494473 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29020608 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25172879 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24288882 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.24015889 |
| 23 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.23495712 |
| 24 | Lysine degradation_Homo sapiens_hsa00310 | 1.22693095 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22530104 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.21814168 |
| 27 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.21038676 |
| 28 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.19745542 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.19527431 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15429363 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13898299 |
| 32 | Prion diseases_Homo sapiens_hsa05020 | 1.13251187 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.12771832 |
| 34 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.12733645 |
| 35 | Prostate cancer_Homo sapiens_hsa05215 | 1.08933285 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06465495 |
| 37 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05751394 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04631410 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03792210 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.02146479 |
| 41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.00972100 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.00117591 |
| 43 | Asthma_Homo sapiens_hsa05310 | 0.98692893 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98305639 |
| 45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.97063548 |
| 46 | Measles_Homo sapiens_hsa05162 | 0.96998083 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95879882 |
| 48 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.95229776 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.94820144 |
| 50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94628923 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93552972 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92244475 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.91945561 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89384812 |
| 55 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88761384 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86927685 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.85086185 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82876012 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 0.82776931 |
| 60 | Malaria_Homo sapiens_hsa05144 | 0.81420128 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 0.80767315 |
| 62 | Bladder cancer_Homo sapiens_hsa05219 | 0.80282073 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79853274 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79224849 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78045457 |
| 66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76558155 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76374760 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76187150 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75341799 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.75277137 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.75087196 |
| 72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74902429 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74797130 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74035295 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.72258379 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71912193 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70941180 |
| 78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70580944 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70475327 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.70367585 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69766670 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69170373 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68344668 |
| 84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.68262897 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.68128696 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68041523 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.67902067 |
| 88 | Tuberculosis_Homo sapiens_hsa05152 | 0.67524552 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.67402742 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.67186958 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.67090541 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66132297 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65969221 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65812805 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65331911 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65010097 |
| 97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64677287 |
| 98 | Hepatitis B_Homo sapiens_hsa05161 | 0.64511524 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64014029 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63886221 |
| 101 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63117622 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62079070 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62019574 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61828329 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61639616 |
| 106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61363883 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60453684 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.59977969 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59648686 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.59512613 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59120390 |
| 112 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58899789 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57351086 |
| 114 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.57110255 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55605275 |
| 116 | Apoptosis_Homo sapiens_hsa04210 | 0.55154743 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55005948 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54671997 |
| 119 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53019692 |
| 120 | Peroxisome_Homo sapiens_hsa04146 | 0.52419661 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52281406 |
| 122 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51692395 |
| 123 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51662975 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49582183 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48835515 |
| 126 | Shigellosis_Homo sapiens_hsa05131 | 0.48809720 |
| 127 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.48305987 |
| 128 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47583227 |
| 129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45746644 |
| 130 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45528524 |
| 131 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45239359 |
| 132 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45239261 |
| 133 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45206473 |
| 134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43856370 |
| 135 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43797906 |

